Growth Metrics

Tandem Diabetes Care (TNDM) Income from Continuing Operations (2016 - 2026)

Tandem Diabetes Care filings provide 13 years of Income from Continuing Operations readings, the most recent being 510000.0 for Q4 2025.

  • On a quarterly basis, Income from Continuing Operations fell 165.81% to 510000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 204631000.0, a 113.23% decrease, with the full-year FY2025 number at 204710000.0, down 113.18% from a year prior.
  • Income from Continuing Operations hit 510000.0 in Q4 2025 for Tandem Diabetes Care, up from 21165000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 10764000.0 in Q4 2021 to a low of 130556000.0 in Q1 2025.
  • Median Income from Continuing Operations over the past 5 years was 22182500.0 (2024), compared with a mean of 30110600.0.
  • Biggest five-year swings in Income from Continuing Operations: surged 161.38% in 2021 and later tumbled 944.34% in 2022.
  • Tandem Diabetes Care's Income from Continuing Operations stood at 10764000.0 in 2021, then crashed by 247.66% to 15894000.0 in 2022, then tumbled by 88.54% to 29967000.0 in 2023, then soared by 102.59% to 775000.0 in 2024, then tumbled by 165.81% to 510000.0 in 2025.
  • The last three reported values for Income from Continuing Operations were 510000.0 (Q4 2025), 21165000.0 (Q3 2025), and 52400000.0 (Q2 2025) per Business Quant data.